Gyre Therapeutics (GYRE) Change in Intangibles (2023)

Gyre Therapeutics (GYRE) has reported Change in Intangibles for 1 consecutive years, with $1.0 million the latest figure, recorded in Q1 2023.

• In Q1 2023, Change in Intangibles changed N/A year-over-year to $1.0 million; the TTM figure through Sep 2023 stood at $1.0 million (changed N/A YoY), while the FY2022 annual figure was $55.0 million, changed N/A from the prior year.
• Change in Intangibles held at $1.0 million in Q1 2023 per GYRE's latest filing.
• Across five years, Change in Intangibles topped out at $1.0 million in Q1 2023 and bottomed at $1.0 million in Q1 2023.